Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes

In type 2 diabetes, hyperglycemia, insulin resistance, increased inflammation, and oxidative stress were shown to be associated with the progressive deterioration of beta-cell function and mass. Short-chain fatty acids (SCFAs) are organic fatty acids produced in the distal gut by bacterial fermentat...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessandra Puddu (Author), Roberta Sanguineti (Author), Fabrizio Montecucco (Author), Giorgio Luciano Viviani (Author)
Format: Book
Published: Hindawi Limited, 2014-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_334d76b2428e42c7ac0d9b34d4f7d131
042 |a dc 
100 1 0 |a Alessandra Puddu  |e author 
700 1 0 |a Roberta Sanguineti  |e author 
700 1 0 |a Fabrizio Montecucco  |e author 
700 1 0 |a Giorgio Luciano Viviani  |e author 
245 0 0 |a Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes 
260 |b Hindawi Limited,   |c 2014-01-01T00:00:00Z. 
500 |a 0962-9351 
500 |a 1466-1861 
500 |a 10.1155/2014/162021 
520 |a In type 2 diabetes, hyperglycemia, insulin resistance, increased inflammation, and oxidative stress were shown to be associated with the progressive deterioration of beta-cell function and mass. Short-chain fatty acids (SCFAs) are organic fatty acids produced in the distal gut by bacterial fermentation of macrofibrous material that might improve type 2 diabetes features. Their main beneficial activities were identified in the decrease of serum levels of glucose, insulin resistance as well as inflammation, and increase in protective Glucagon-like peptide-1 (GLP-1) secretion. In this review, we updated evidence on the effects of SCFAs potentially improving metabolic control in type 2 diabetes. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 2014 (2014) 
787 0 |n http://dx.doi.org/10.1155/2014/162021 
787 0 |n https://doaj.org/toc/0962-9351 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/334d76b2428e42c7ac0d9b34d4f7d131  |z Connect to this object online.